ClinicalTrials.govpublic full text
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
b-cell adult acute lymphoblastic leukemia, stem cell leukemia, minimal residual disease, acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 811769
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.